ARK Genomic Revolution ETF vs Dow Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Dow Inc trades at $31.07 (market cap $22.58B). The key difference: Dow Inc pays a 4.48% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Dow Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | DOW | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $44.55 | $41.87 |
52-Week Low | $24.02 | $20.65 |
Market Cap | — | $22.58B |
Enterprise Value | — | $38.27B |
Dividend Yield | — | 4.48% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →